Michael Siekman > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile
McDermott Will & Emery LLP Offices
![McDermott Will & Emery LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/50652.jpg?v=1653318587)
28 STATE STREET
BOSTON, MA 02109-1775
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Michael Siekman
![Michael Siekman photo](https://www.legal500.com/wp-content/uploads/sites/13/2022/06/SIEKMAN_M_19493_T-300x300.jpg)
Work Department
IP Prosecution, Transactions & Strategy
Position
Michael Siekman focuses his practice on intellectual property matters, including patent prosecution, licensing and post-grant proceedings and litigation. Leveraging over 25 years of experience, Michael has built in-depth patent portfolios, advising clients in the biotechnology and pharmaceutical industries.
Michael keeps clients’ business goals in mind as he regularly provides legal counsel in the litigation matters, including Hatch-Waxman matters, and post-grant solutions for biosimilars. He has successfully led matters before the Patent Trial and Appeal Board (PTAB) and the European Patent Office. His licensing practice involves IP-related aspects of mergers, acquisitions, IPOs and other financing and licensing programs.
Please visit McDermott website for full biography: https://www.mwe.com/people/michael-siekman/
Top Tier Firm Rankings
- Media, technology and telecoms > Technology transactions
- Healthcare > Health insurers
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: electric power
- Tax > Financial products
- Labor and employment > Immigration
- Tax > International tax
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Real estate > Real estate finance
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Government > Government contracts
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: derivatives and structured products
- International trade > Trade remedies and trade policy
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > International arbitration
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Finance > Fintech